MECKI-Amyloidosis: Assessment of the Exercise Capacity and Prognosis of Patients with Cardiac Amyloidosis
RecruitingOBSERVATIONAL
Enrollment
1,400
Participants
Timeline
Start Date
May 7, 2024
Primary Completion Date
May 31, 2026
Study Completion Date
May 31, 2027
Conditions
Cardiac Amyloidosis
Trial Locations (1)
20138
RECRUITING
Centro Cardiologico Monzino, Irccs, Milan
All Listed Sponsors
lead
Centro Cardiologico Monzino
OTHER
NCT06799273 - MECKI-Amyloidosis: Assessment of the Exercise Capacity and Prognosis of Patients with Cardiac Amyloidosis | Biotech Hunter | Biotech Hunter